ESTRO PT 2018

Clinical Trials (active or completed) in Particle Therapy: The PTCOG List

* Information compiled by PTCOG from particle therapy centers and from ClinicalTrials.gov – January 2016

Column1 Column2

Column3 Column4

Column5

Column6 Column7 Column8

Disease Site Total

Randomized / P III

P I/II P0 / Pilot / Reg

Completed

C-Ion

Breast (PB, Lymphnodes, Hodgkins,…) CNS (Skull Base, Spine, Brain, …) Eye (Melanoma, Retinoblastoma, Mdeg, …) GI (upper GI, Esophageal, Rectum, …)

14 25

1 2

9

4 6

2 1

17

5

9 6

0 1

6 2

3 3

2 3

1

H&N Nasal Cavity, Nasopharynx, Oropharynx,…)

20 27

2 1 0 2 0 0 8 0

7

11 10

5 7 1 3 1 4 4 0

6

Lung (NSCLC)

16

Lymphoma (Hodgkin Lymphoma, …)

4

1

3 4 0

GI (Liver)

16 12

10 12

GI (Pancreas)

1

Pediatrics (CNS, RMS, Meduloblastoma, H&N, Brain, ...)

23 24

11

12

GU (Prostate)

9 1

7 1

1

GU (Bladder, Gyn)

2

Sarcoma (Chordoma, Chondrosarkoma, Spine, …)

17

1

13

3

4

2

Total

199

18 114

67

37 16

Note: Data form centers in Japan largely not reported to PTCOG